Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23531244 | 1.00 | TSHR (0.48) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL10829234 | 0.87 | MMP12 (0.50) | ALDH1A1CYP1A2 | |
| SCHEMBL920968 | 0.86 | SIGMAR1 (0.47) | MEN1KMT2A | |
| SCHEMBL10697566 | 0.85 | TSHR (0.52) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL21625271 | 0.85 | SIGMAR1 (0.49) | — | |
| SCHEMBL4785593 | 0.80 | TSHR (0.52) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL167715 | 0.80 | AOC3 (0.55) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL7441548 | 0.80 | ALDH1A1 (0.48) | TSHRALDH1A1HPGDSMN1; SMN2ALOX15 | |
| Ammonia Solution, Strong SCHEMBL4461727 | 0.78 | AOC3 (0.53) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| Hydrogen Peroxide SCHEMBL9581085 | 0.78 | TSHR (0.55) | TSHRPOLBMEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108690217-B | Carbon fiber recycling composition and method | 波音公司 | 2022-07-15 | — | — | CN | claimed |
| US-11377535-B2 | Carbon fiber recovery compositions and methods | THE BOEING COMPANY (US) | 2022-07-05 | — | — | US | claimed |
| US-20200207940-A1 | Carbon Fiber Recovery Compositions and Methods | THE BOEING COMPANY | 2020-07-02 | — | — | US | claimed |
| US-10611892-B2 | Carbon fiber recovery compositions and methods | THE BOEING COMPANY (US) | 2020-04-07 | — | — | US | claimed |
| US-20180291174-A1 | Carbon Fiber Recovery Compositions and Methods | THE BOEING COMPANY | 2018-10-11 | — | — | US | claimed |
| US-7402576-B2 | Phosphinic acid analogs of glutamate | GIVAUDAN SA (CH) | 2008-07-22 | — | — | US | claimed |
| EP-1599487-B1 | PHOSPHINIC ACID ANALOGS OF GLUTAMATE | GIVAUDAN SA (CH) | 2007-07-11 | — | — | EP | claimed |
| US-20060052616-A1 | Phosphinic acid analogs of glutamate | GIVAUDAN SA (CH) | 2006-03-09 | — | — | US | claimed |
| CN-1705674-A | phosphinic acid analogs of glutamic acid | GIVAUDAN SA (CH) | 2005-12-07 | — | — | CN | claimed |
| WO-2004048394-A1 | PHOSPHINIC ACID ANALOGS OF GLUTAMATE | GIVAUDAN SA (CH) | 2004-06-10 | — | — | WO | claimed |
| US-20240148727-A1 | OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2024-05-09 | — | — | US | disclosed |
| US-11911381-B2 | Optically active azabicyclo ring derivative | Sumitomo Pharma Co., Ltd. (JP) | 2024-02-27 | — | — | US | disclosed |
| CN-112771055-B | Optically active bridged piperidine derivatives | 住友制药株式会社 | 2023-10-20 | — | — | CN | disclosed |
| CN-112585140-B | Optically active azabicyclo derivatives | 住友制药株式会社 | 2023-07-04 | — | — | CN | disclosed |
| CN-108690217-B | Carbon fiber recycling composition and method | 波音公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-1049664-A | Optically active 4-hydroxyl-8-(3-low-alkoxy-4-phenyl sulfinyl phenyl) pyrazolo [1,5-α]-1,3,5-triazines salt and method for making thereof | OTSUKA PHARMA CO LTD (JP) | 1991-03-06 | — | — | CN | disclosed |
| US-4302588-A | 5-(3-SUBSTITUTED AMINO)-2-HYDROXY-PROPYLOXY)-8-HYDROXY OR ALKOXY-CARBOSTYRILS, ADRENERGIC BLOCKING AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1981-11-24 | — | — | US | disclosed |
| US-4289883-A | ADRENERGIC BLOCKING AGENTS OF EXCELLENT CARDIOSELECTIVITY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1981-09-15 | — | — | US | disclosed |
| US-4210753-A | TREATMENT OF CARDIAC DISORDERS AND CHRONIC LUNG DISEASE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1980-07-01 | — | — | US | disclosed |
| US-4147869-A | ADRENERGIC BLOCKING AGENTS FOR TREATMENT OF ANGINA PECTORIS, ARRHYTHMIA AND HYPERTENSION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1979-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052616-A1 | Phosphinic acid analogs of glutamate | GLUL, GRIA1, GRM1 | TSHR 2006/4885POLB 3981/4885MEN1 1644/4885 |
| US-11911381-B2 | Optically active azabicyclo ring derivative | MLLT3, MEN1, MLLT1 | TSHR 3525/4885POLB 4302/4885MEN1 2/4885 |
| US-20240148727-A1 | OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVE | MLLT3, MEN1, MLLT1 | TSHR 3525/4885POLB 4302/4885MEN1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.